These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2257249

  • 1. Calcitonin, estrogens and the bone.
    Gennari C, Agnusdei D.
    J Steroid Biochem Mol Biol; 1990 Nov 20; 37(3):451-5. PubMed ID: 2257249
    [Abstract] [Full Text] [Related]

  • 2. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
    Civitelli R, Agnusdei D, Nardi P, Zacchei F, Avioli LV, Gennari C.
    Calcif Tissue Int; 1988 Feb 20; 42(2):77-86. PubMed ID: 3127028
    [Abstract] [Full Text] [Related]

  • 3. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC, Abeyasekera G, Hillyard CJ, Phang KG, MacIntyre I, Campbell S, Townsend PT, Young O, Whitehead MI.
    Lancet; 1981 Mar 28; 1(8222):693-5. PubMed ID: 6110915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects in postmenopausal women of natural and synthetic estrogens on calcitonin and calcium-regulating hormone secretion. Relevance to postmenopausal osteoporosis.
    Whitehead MI, Lane G, Townsend PT, Abeyasekera G, Hillyard CJ, Stevenson JC.
    Acta Obstet Gynecol Scand Suppl; 1981 Mar 28; 106():27-32. PubMed ID: 6951874
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr 28; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 10. Hormonal alterations and osteoporotic syndromes.
    Avioli LV.
    J Bone Miner Res; 1993 Dec 28; 8 Suppl 2():S511-4. PubMed ID: 8122520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
    Gennari C, Agnusdei D, Nardi P, Civitelli R.
    J Clin Endocrinol Metab; 1990 Nov 28; 71(5):1288-93. PubMed ID: 2229286
    [Abstract] [Full Text] [Related]

  • 13. Effects of salmon calcitonin on the bone loss induced by ovariectomy.
    Mazzuoli GF, Tabolli S, Bigi F, Valtorta C, Minisola S, Diacinti D, Scarnecchia L, Bianchi G, Piolini M, Dell'Acqua S.
    Calcif Tissue Int; 1990 Oct 28; 47(4):209-14. PubMed ID: 2242492
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacologic therapy of osteoporosis].
    Kushida K.
    Nihon Rinsho; 1994 Sep 28; 52(9):2367-77. PubMed ID: 7967083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC, Fowler SE, Detter JR, Sherman SS.
    J Clin Endocrinol Metab; 2001 Aug 28; 86(8):3618-28. PubMed ID: 11502787
    [Abstract] [Full Text] [Related]

  • 17. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
    Riggs BL.
    Endocrinol Jpn; 1979 Jun 28; 26(Suppl):31-41. PubMed ID: 467347
    [Abstract] [Full Text] [Related]

  • 18. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
    Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli R, Valtorta C, Palummeri E, Cervellin GF, Gonnelli S, Francini G.
    Calcif Tissue Int; 1986 Jan 28; 38(1):3-8. PubMed ID: 3079649
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, Olson M, Benmammar H, Mindeholm L, Azria M, Christiansen C.
    J Bone Miner Res; 2004 Sep 28; 19(9):1531-8. PubMed ID: 15312255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.